Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression

INTRODUCTION: Unboosted atazanavir (ATV) including regimens have been investigated as a ritonavir-sparing simplification strategy. No data are available on removal of one NRTI in subjects effectively treated with unboosted atazanavir+2NRTIs. We present the 48-week virological efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Alessia, Galli, Laura, Bigoloni, Alba, Bossolasco, Simona, Guffanti, Monica, Maillard, Miriam, Carini, Elisabetta, Salpietro, Stefania, Spagnuolo, Vincenzo, Gianotti, Nicola, Lazzarin, Adriano, Castagna, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P279
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225246/
https://www.ncbi.nlm.nih.gov/pubmed/25397555
http://dx.doi.org/10.7448/IAS.17.4.19811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225246/
https://www.ncbi.nlm.nih.gov/pubmed/25397555
http://dx.doi.org/10.7448/IAS.17.4.19811

Ejemplares similares